- Home
- AGEN vs SND Comparison
AGEN vs SND Comparison
Compare AGEN & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- SND
- Stock Information
- Founded
- AGEN 1994
- SND 2011
- Country
- AGEN United States
- SND United States
- Employees
- AGEN N/A
- SND N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- AGEN Health Care
- SND Industrials
- Exchange
- AGEN Nasdaq
- SND Nasdaq
- Market Cap
- AGEN 96.2M
- SND 104.7M
- IPO Year
- AGEN 2000
- SND 2016
- Fundamental
- Price
- AGEN $2.83
- SND $2.13
- Analyst Decision
- AGEN Buy
- SND Hold
- Analyst Count
- AGEN 3
- SND 2
- Target Price
- AGEN $10.50
- SND $2.63
- AVG Volume (30 Days)
- AGEN 566.5K
- SND 120.6K
- Earning Date
- AGEN 11-12-2024
- SND 11-12-2024
- Dividend Yield
- AGEN N/A
- SND N/A
- EPS Growth
- AGEN N/A
- SND N/A
- EPS
- AGEN N/A
- SND N/A
- Revenue
- AGEN $160,427,000.00
- SND $281,956,000.00
- Revenue This Year
- AGEN N/A
- SND N/A
- Revenue Next Year
- AGEN $36.13
- SND $4.51
- P/E Ratio
- AGEN N/A
- SND N/A
- Revenue Growth
- AGEN 59.00
- SND N/A
- 52 Week Low
- AGEN $2.50
- SND $1.65
- 52 Week High
- AGEN $19.69
- SND $2.80
- Technical
- Relative Strength Index (RSI)
- AGEN 39.40
- SND 40.29
- Support Level
- AGEN $2.65
- SND $2.05
- Resistance Level
- AGEN $3.85
- SND $2.40
- Average True Range (ATR)
- AGEN 0.29
- SND 0.11
- MACD
- AGEN -0.02
- SND -0.03
- Stochastic Oscillator
- AGEN 15.00
- SND 16.33
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About SND Smart Sand Inc.
Smart Sand Inc is a fully integrated frac sand supply and services company that offers complete mine-to-well site proppant supply and logistics solutions. It produces Northern White frac sand, which is a premium proppant used to enhance hydrocarbon recovery rates in the hydraulic fracturing of oil and natural gas wells. Its product portfolio includes Smart System, which includes SmartBelt, SmartDepot Silo and SmartPath Loader. The company caters its products and services to oil and natural gas exploration and production companies and oilfield service companies. The majority of its revenue comes from Sand Sales, followed by logistics.